Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth

Raghvendra K. Dubey, Delbert G. Gillespie, Lefteris C. Zacharia, Marinella Rosselli, Bruno Imthurn, Edwin K. Jackson

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Estradiol inhibits cardiac fibroblast growth and may protect against cardiac remodeling associated with heart disease. However, the mechanisms by which estradiol attenuates cardiac fibroblast growth remain unclear. Because cardiac fibroblasts express cytochrome P450s (CYP450s) and catechol-O-methyltransferase (COMT) capable of converting estradiol to hydroxyestradiols and methoxyestradiols, respectively, and because hydroxyestradiols and methoxyestradiols (estradiol metabolites with little affinity for estrogen receptors) are potent inhibitors of cardiac fibroblast growth, we hypothesized that the antimitogenic effects of estradiol are mediated via hydroxyestradiols and/or methoxyestradiols. The inhibitory effects of estradiol (1 to 100 nmol/L) on serum-stimulated 3H-thymidine incorporation (DNA synthesis), 3H-proline incorporation (collagen synthesis), and cell number (proliferation) were enhanced (P<0.005) by CYP450 inducers 3-methylcholanthrene (10 μmol/L) and phenobarbital (10 μmol/L). Moreover, the inhibitory effects of estradiol were blocked by the CYP450 inhibitor 1-aminobenzotriazole (10 μmol/L) and the COMT inhibitors quercetin (10 μmol/L) and OR486 (10 μmol/L). In contrast to estradiol, the modulators of CYP450 and COMT were poor ligands for estrogen receptors (binding affinity ≤0.0001% versus estradiol). In cardiac fibroblasts, both quercetin and OR486 inhibited the metabolism of hydroxyestradiol to methoxyestradiol and blocked the inhibitory effects of hydroxyestradiol on cardiac fibroblast proliferation and DNA and collagen synthesis. The abrogating effects of quercetin and OR486 on the metabolism and antimitogenic effects of 2-hydroxyestradiol were mimicked by 20 μmol/L norepinephrine and isoproterenol, substrates for COMT. Our findings provide evidence that estradiol can inhibit cardiac fibroblast growth via an estrogen receptor-independent pathway that involves the local metabolism of estradiol to methoxyestradiols.

Original languageEnglish
Pages (from-to)412-417
Number of pages6
JournalHypertension
Volume39
Issue number2 II
DOIs
Publication statusPublished - 2002

Keywords

  • Cardiovascular diseases
  • Fibroblasts
  • Hormones
  • Menopause
  • Metabolism

Fingerprint Dive into the research topics of 'Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth'. Together they form a unique fingerprint.

  • Cite this